Quest Diagnostics (DGX)
Quest Diagnostics Max Pain By Strike
DGX trades at $180.09, 2.9% above the near-term max pain of $175 expiring Aug 15, 2025 (0 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($90-$175), signaling increased put positioning or downside protection. Key magnetic zone at 165 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Quest Diagnostics Max Pain By Expiry
Max pain for DGX shows a downward trend from 175 to 90, indicating bearish sentiment or hedging activity. The 56% spread signals divergent expectations across timeframes. Most levels below 180.09 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 175 | -5.09 (-2.82%) |
| Sep 19, 2025 | 175 | -5.09 (-2.82%) |
| Oct 17, 2025 | 125 | -55.09 (-30.59%) |
| Nov 21, 2025 | 170 | -10.09 (-5.60%) |
| Dec 19, 2025 | 160 | -20.09 (-11.15%) |
| Jan 16, 2026 | 165 | -15.09 (-8.38%) |
| Feb 20, 2026 | 165 | -15.09 (-8.38%) |
| Mar 20, 2026 | 90 | -90.09 (-50.02%) |